REPX shareholder Bobby Riley files notice to sell 20,000 shares
Rhea-AI Filing Summary
Bobby Riley has filed a notice of proposed sale for up to 20,000 shares of common stock, with an aggregate market value of $531,600. The shares are expected to be sold on the NYSE around December 18, 2025 through broker Charles Schwab.
The shares to be sold were acquired as equity compensation via vested restricted stock awards on September 27, 2025 (12,663 shares) and October 1, 2025 (7,337 shares). Over the past three months, Riley has already sold 12,500 shares of the issuer’s common stock for gross proceeds of $312,715.42. The filing notes that 21,968,906 shares of this class of common stock are outstanding.
Positive
- None.
Negative
- None.
FAQ
What does this filing about REPX disclose regarding share sales?
The filing shows that Bobby Riley has filed a notice of proposed sale for up to 20,000 shares of common stock, with an aggregate market value of $531,600, to be sold on the NYSE through broker Charles Schwab.
How many REPX shares does Bobby Riley plan to sell and on which exchange?
Bobby Riley plans to sell up to 20,000 shares of common stock, listed for sale on the NYSE, through Charles Schwab Corp. as broker.
How were the REPX shares being sold acquired?
The shares being sold were acquired as equity compensation via vested restricted stock awards (RSAs): 12,663 shares on September 27, 2025 and 7,337 shares on October 1, 2025, both from the issuer.
Has Bobby Riley sold REPX shares in the last three months?
Yes. Over the past three months, Bobby Riley sold 12,500 shares of the issuer’s common stock on November 1, 2025, generating $312,715.42 in gross proceeds.
What is the total number of REPX shares outstanding for this class?
The filing reports that there are 21,968,906 shares of this class of common stock outstanding.
When are the REPX shares expected to be sold under this notice?
The approximate date of sale listed is December 18, 2025, with the common stock to be sold on the NYSE.